ClinicalTrials.govpublic full text
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
adult acute myeloid leukemia in remission, acute biphenotypic leukemia, early relapse of acute myeloid leukemia, late relapse of acute myeloid leukemia, recurrent adult acute myeloid leukemia, secondary acute myeloid leukemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 349954
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.